Ivermectin for Humans: Uses, Dosage, and Safety

Available by prescription only

Ivermectin (Stromectol) is dispensed through licensed U.S. pharmacies following evaluation and prescription by a qualified healthcare provider.

Ivermectin 3 MG
From $ 2.34 Per pill
Ivermectin 3 MG
From $ 1.60 Per pill
Ivermectin 3 MG
From $ 2.36 Per pill

Persistent skin itching, recurring rashes, or unexplained gastrointestinal symptoms — particularly following travel to tropical or subtropical regions — can indicate an active parasitic infection. Left untreated, conditions such as strongyloidiasis can progress to severe, systemic disease in immunocompromised individuals, while onchocerciasis carries a risk of irreversible vision loss if not managed appropriately.

Misidentifying these symptoms or attempting to self-treat with unverified medications carries its own risks: incorrect dosing, counterfeit products, and delayed diagnosis of a potentially serious underlying condition.

Ivermectin (Stromectol) is one of the most clinically validated antiparasitic medications available, with over three decades of use across FDA-approved indications including onchocerciasis, strongyloidiasis, and scabies. When prescribed and dosed correctly, it offers a well-established safety and efficacy profile.

Because dosing is weight-based and indication-specific, a formal clinical evaluation by a licensed healthcare provider is required before treatment can begin — both to confirm the diagnosis and to ensure the regimen is appropriate for the individual patient.

Table of Contents

What Is Ivermectin Used For?

Ivermectin belongs to the antiparasitic drug class and is FDA-approved for the treatment of the following conditions in humans:1

  • Onchocerciasis (river blindness) — caused by Onchocerca volvulus, a parasitic worm transmitted through black fly bites, endemic in sub-Saharan Africa and parts of Latin America.
  • Strongyloidiasis — an intestinal infection caused by Strongyloides stercoralis, prevalent in tropical and subtropical regions, capable of causing autoinfection in immunocompromised individuals.
  • Scabies — a skin infestation caused by Sarcoptes scabiei, typically managed with topical treatment but sometimes requiring oral Ivermectin for crusted or treatment-resistant cases.
  • Pediculosis (certain lice infestations) — off-label use supported by clinical evidence in cases resistant to topical agents.

In some cases, physicians may prescribe Ivermectin off-label for other parasitic or dermatologic conditions under professional supervision and with appropriate clinical justification.

How Ivermectin Works

Ivermectin acts by binding selectively to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells. This binding increases cell membrane permeability to chloride ions, leading to hyperpolarization of the nerve or muscle cell, resulting in paralysis and death of the parasite.2

Ivermectin has high affinity for these channels in parasites and very low affinity for mammalian central nervous system receptors — in part because it does not cross an intact blood-brain barrier at therapeutic doses. This selective toxicity accounts for its favorable safety profile in humans when taken as directed.

It is effective against a range of helminthic (worm) and ectoparasitic species and is generally well-tolerated when prescribed appropriately.

Dosage and Administration

Dosing is weight-based and varies by indication. The standard dosing guidelines are summarized below:

Indication Dose Frequency
Onchocerciasis (river blindness) 150 mcg/kg body weight Single dose; repeat at 6–12 month intervals as directed
Strongyloidiasis 200 mcg/kg body weight Single dose; may repeat in 2 weeks if warranted
Scabies (crusted or resistant) 200 mcg/kg body weight Single dose; often repeated at Day 8 and Day 15

Administration instructions:

  • Take on an empty stomach with a full glass of water.
  • Administer at least one hour before or two hours after a meal to maximize absorption.
  • Swallow tablets whole — do not crush or chew.
  • Follow your healthcare provider’s instructions precisely. Do not adjust your dose or frequency without medical guidance.

Dosing in pediatric patients, elderly patients, and those with hepatic impairment must be determined by a qualified clinician on a case-by-case basis.

Contraindications

Ivermectin is contraindicated in the following situations:

  • Known hypersensitivity to ivermectin or any component of the formulation.
  • Concurrent use of medications that interact with P-glycoprotein or CNS-depressant drugs in ways that may increase Ivermectin CNS penetration (see Drug Interactions below).
  • High-intensity Loa loa infection: In individuals with high Loa loa microfilarial loads (generally ≥30,000 mf/mL), Ivermectin administration has been associated with serious and potentially fatal encephalopathy. A Loa loa assessment is recommended before treatment in patients from endemic regions of Central and West Africa.3

Use in pregnancy is not recommended unless the potential benefit clearly outweighs fetal risk. Ivermectin is excreted in breast milk; use during breastfeeding should only occur under direct clinical supervision.

Drug Interactions

Ivermectin may interact with several medications. Inform your prescriber of all drugs, supplements, and herbal products you are currently taking before starting treatment.

Notable interactions include:

  • Warfarin: Ivermectin may increase anticoagulant effect. INR monitoring is advised.
  • Barbiturates, benzodiazepines, valproic acid, and other CNS depressants: May increase CNS exposure to Ivermectin, particularly in patients with compromised blood-brain barrier integrity.
  • Strong P-glycoprotein inhibitors (e.g., certain immunosuppressants): May increase Ivermectin plasma concentrations.
  • Alcohol: Concurrent use is not recommended due to potential additive CNS effects.

This is not a complete list of interactions. Your healthcare provider or pharmacist should review your full medication list prior to prescribing.

Side Effects and Safety

Ivermectin is generally well-tolerated when taken at prescribed doses. Reported adverse effects include:

Common (may affect up to 1 in 10 users):

  • Nausea, diarrhea, abdominal discomfort
  • Dizziness or lightheadedness
  • Pruritus (itching) or skin rash

Less common or serious:

  • Mazzotti reaction — an inflammatory response that can occur in patients with onchocerciasis following Ivermectin treatment, presenting as fever, urticaria, tachycardia, edema, and arthralgias. This is a reaction to dying parasites, not a drug allergy. It is usually managed symptomatically.
  • Neurological symptoms (confusion, ataxia, altered consciousness) — rare; more likely in patients with underlying CNS vulnerability or excessively high exposures.
  • Visual disturbances — reported primarily in the context of onchocerciasis treatment.
  • Hypotension — uncommon; patients should be monitored after initial dosing in high-risk settings.

Warning: Seek immediate medical attention if you experience difficulty breathing, chest tightness, severe neurological symptoms, or signs of severe allergic reaction (angioedema, anaphylaxis).

People with liver disease, underlying neurological conditions, or those taking interacting medications should discuss the benefit-risk profile with their provider before initiating treatment.

Monitoring and Follow-up

A single-dose regimen does not eliminate the need for clinical follow-up. Your provider may recommend:

  • Stool examination or serology (for strongyloidiasis) to confirm eradication, typically 2–4 weeks post-treatment.
  • Skin snip examination (for onchocerciasis) at periodic intervals to assess microfilarial load.
  • Repeat dosing per CDC guidelines if reinfection risk remains or initial treatment response is incomplete.2
  • Clinical reassessment if symptoms persist or worsen after treatment.

Patients who are immunocompromised (e.g., due to HIV, corticosteroid use, or organ transplant) may require extended treatment protocols for strongyloidiasis and should remain under close monitoring.

Ivermectin and COVID-19 — What the Evidence Shows

During the COVID-19 pandemic, Ivermectin received significant attention for potential antiviral properties based on early in vitro data.

However, large-scale randomized controlled trials, including the ACTIV-6 and TOGETHER trials, did not demonstrate a clinically meaningful benefit of Ivermectin in the treatment of COVID-19 in outpatient populations.

The U.S. FDA, CDC, and WHO have each concluded that Ivermectin is not approved or recommended for the prevention or treatment of COVID-19 outside of formally controlled clinical research settings.3

Its approved use remains limited to parasitic infections in humans. Antiviral use outside of a clinical trial context is not supported by current evidence and is not endorsed by regulatory authorities.

See official FDA guidance on Ivermectin and COVID-19

How to Access Ivermectin Legally in the U.S.

In the United States, Ivermectin is classified as a prescription-only medication. It cannot be legally dispensed without a valid prescription issued by a licensed healthcare provider.

Patients may obtain a prescription through:

  • In-person clinical evaluation with a primary care physician, infectious disease specialist, or dermatologist.
  • Remote evaluation through a licensed healthcare provider via a compliant telehealth platform, where clinically appropriate and permitted by applicable state law.
  • Certified U.S. pharmacies — both retail and mail-order — upon presentation of a valid prescription.

When purchasing online, verify that the pharmacy is U.S.-licensed and accredited by the VIPPS (Verified Internet Pharmacy Practice Sites) program, operated by the National Association of Boards of Pharmacy (NABP).

Important: Avoid any website offering Ivermectin without requiring a prescription. These sources frequently sell counterfeit, contaminated, or veterinary-formulated products that are not approved or safe for human use. Veterinary formulations (e.g., ivermectin paste for horses) contain different concentrations and excipients and have caused serious adverse events in humans when misused.

Pricing and Availability

The generic version of Ivermectin (3 mg tablets) is widely available and substantially more affordable than the brand-name Stromectol, while maintaining the same active compound, bioavailability, and therapeutic effect.

Typical retail costs through licensed U.S. pharmacies range from a few dollars per tablet, though pricing varies depending on insurance coverage, dispensing pharmacy, and prescription quantity. Patients using manufacturer programs or pharmacy discount cards may access further reductions.

Healthcare provider consultation fees — whether in-person or via a licensed telehealth platform — are separate and vary by provider.

Frequently Asked Questions About Ivermectin

Can I obtain Ivermectin online in the U.S.?

Yes, but only through licensed U.S. pharmacies that dispense the medication upon receipt of a valid prescription from a certified provider. A clinical evaluation must occur before a prescription is issued.

What is the standard adult dosage?

Dosing is weight-based and indication-specific, typically ranging from 150 to 200 mcg/kg as a single oral dose. The correct dose must be determined by your prescribing provider.

Is Ivermectin safe for children?

Ivermectin is generally used in children weighing 15 kg or more for approved indications. Dosing in pediatric patients must be determined by a qualified healthcare provider.

Can Ivermectin be used during pregnancy or breastfeeding?

It is not recommended during pregnancy without clear clinical justification. It is excreted in breast milk; use during breastfeeding should be supervised directly by a clinician.

Does Ivermectin treat viral infections, including COVID-19?

No. Its FDA-approved indications are limited to parasitic infections. Its use for COVID-19 is not supported by current clinical trial evidence and is not recommended by the FDA, CDC, or WHO.

What should I do if I miss a dose?

Contact your prescribing provider for guidance. Do not take a double dose unless specifically advised to do so.

Is there a difference between human and veterinary Ivermectin formulations?

Yes. Veterinary formulations are not approved for human use and can contain concentrations or ingredients that pose serious health risks. Only use FDA-approved human formulations obtained through a licensed pharmacy.

Key Clinical Takeaways

  • Ivermectin (Stromectol) is an FDA-approved antiparasitic medication with a well-established safety and efficacy profile for approved indications.
  • It is available by prescription only in the United States and must be obtained through a licensed pharmacy following a clinical evaluation.
  • Dosing is weight-based and indication-specific; self-dosing is associated with significant risk.
  • It is not approved for COVID-19 treatment or prevention.
  • Patients should complete recommended follow-up to confirm treatment success and prevent recurrence.
  • Veterinary formulations of ivermectin are not safe or appropriate for human use.

References and Resources

Reviewed by: Nettie C. McCoy, M.D.
Last Updated: October 2025
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional before starting or modifying any medication regimen.